Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a large growth in short interest in the month of March. As of March 13th, there was short interest totaling 23,692 shares, a growth of 45.3% from the February 26th total of 16,307 shares. Based on an average trading volume of 73,206 shares, the days-to-cover ratio is presently 0.3 days. Currently, 1.5% of the shares of the company are sold short.

Arcadia Biosciences Stock Performance

RKDA stock traded down $0.05 during midday trading on Friday, reaching $1.47. 21,056 shares of the company’s stock traded hands, compared to its average volume of 54,657. The firm has a market capitalization of $2.54 million, a PE ratio of -0.85 and a beta of 0.57. The company has a 50-day moving average price of $1.89 and a two-hundred day moving average price of $2.93. Arcadia Biosciences has a 52 week low of $1.46 and a 52 week high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last announced its quarterly earnings results on Thursday, March 26th. The basic materials company reported ($0.97) earnings per share for the quarter, missing the consensus estimate of ($0.66) by ($0.31). Arcadia Biosciences had a negative net margin of 48.15% and a positive return on equity of 34.16%. The company had revenue of $0.90 million during the quarter, compared to analysts’ expectations of $1.40 million.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arcadia Biosciences in a report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.